Illumina Debuts BeadXpress, Hopes FDA Will See First Dxs in '08; Homebrew Options Open | GenomeWeb
Illumina this week launched its BeadXpress system, a platform for research and clinical development applications that uses its VeraCode digital microbead technology, rather than its arrays, as its foundation.
 
The company said it has signed four collaborations since May 2006 to use the BeadXpress as a platform to deploy diagnostic content. Illumina also said it could file tests for US regulatory approval sometime next year, and BeadXpress customers may in the future use the platform to develop homebrew tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.